OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenic Cell Death Induction by Ionizing Radiation
Mengqin Zhu, Mengdie Yang, Jiajia Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 169
Mengqin Zhu, Mengdie Yang, Jiajia Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 169
Showing 1-25 of 169 citing articles:
Immunogenic Cell Death Augmented by Manganese Zinc Sulfide Nanoparticles for Metastatic Melanoma Immunotherapy
Zhu Li, Zhaoyou Chu, Juan Yang, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 15471-15483
Closed Access | Times Cited: 135
Zhu Li, Zhaoyou Chu, Juan Yang, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 15471-15483
Closed Access | Times Cited: 135
Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation
Shanshan Xie, Yan Deng, Shenglan Guo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 88
Shanshan Xie, Yan Deng, Shenglan Guo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 88
Multifunctional inorganic nanomaterials for cancer photoimmunotherapy
Lu Tang, Aining Zhang, Ziyao Zhang, et al.
Cancer Communications (2022) Vol. 42, Iss. 2, pp. 141-163
Open Access | Times Cited: 81
Lu Tang, Aining Zhang, Ziyao Zhang, et al.
Cancer Communications (2022) Vol. 42, Iss. 2, pp. 141-163
Open Access | Times Cited: 81
Tantalum–Zirconium Co‐Doped Metal–Organic Frameworks Sequentially Sensitize Radio–Radiodynamic–Immunotherapy for Metastatic Osteosarcoma
Tao Li, Mingquan Gao, Zifei Wu, et al.
Advanced Science (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 44
Tao Li, Mingquan Gao, Zifei Wu, et al.
Advanced Science (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 44
Self‐Cascade Nanozyme Reactor as a Cuproptosis Inducer Synergistic Inhibition of Cellular Respiration Boosting Radioimmunotherapy
Rui Li, Weiheng Zhao, Zhuo Han, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 24
Rui Li, Weiheng Zhao, Zhuo Han, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 24
Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity
Shirley Lewis, Laura A. Dawson, Aisling Barry, et al.
JHEP Reports (2022) Vol. 4, Iss. 8, pp. 100498-100498
Open Access | Times Cited: 55
Shirley Lewis, Laura A. Dawson, Aisling Barry, et al.
JHEP Reports (2022) Vol. 4, Iss. 8, pp. 100498-100498
Open Access | Times Cited: 55
Nanoscale Zeolitic Imidazolate Framework (ZIF)–8 in Cancer Theranostics: Current Challenges and Prospects
Hongxin Xie, Xinyu Liu, Zhengrong Huang, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3935-3935
Open Access | Times Cited: 51
Hongxin Xie, Xinyu Liu, Zhengrong Huang, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3935-3935
Open Access | Times Cited: 51
Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 40
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 40
Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
Xuhui Bao, Liyi Xie
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 39
Xuhui Bao, Liyi Xie
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 39
Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM
Bao Liu, Qifeng Ji, Ying Cheng, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 37
Bao Liu, Qifeng Ji, Ying Cheng, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 37
Multifunctional Nano‐Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death
Qian Chen, Chunyan Li, Qiangbin Wang
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 30
Qian Chen, Chunyan Li, Qiangbin Wang
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 30
Fe-MnO2 nanosheets loading dihydroartemisinin for ferroptosis and immunotherapy
Dandan Huang, Dafen Xu, Wenxin Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114431-114431
Open Access | Times Cited: 27
Dandan Huang, Dafen Xu, Wenxin Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114431-114431
Open Access | Times Cited: 27
Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Open Access | Times Cited: 26
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Open Access | Times Cited: 26
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 12
Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 12
Octadecyl Gallate and Lipid‐Modified MnSe2 Nanoparticles Enhance Radiosensitivity in Esophageal Squamous Cell Carcinoma and Promote Radioprotection in Normal Tissues
Xinyue Li, He Liu, Wenyan Gao, et al.
Advanced Materials (2024) Vol. 36, Iss. 23
Closed Access | Times Cited: 12
Xinyue Li, He Liu, Wenyan Gao, et al.
Advanced Materials (2024) Vol. 36, Iss. 23
Closed Access | Times Cited: 12
Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches
Ahmed O. Elzoghby, Omar Samir, Hagar E. S. Emam, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2475-2504
Open Access | Times Cited: 9
Ahmed O. Elzoghby, Omar Samir, Hagar E. S. Emam, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2475-2504
Open Access | Times Cited: 9
Research progress in inducing immunogenic cell death of tumor cells
Deqian Xie, Qifei Wang, Guangzhen Wu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Deqian Xie, Qifei Wang, Guangzhen Wu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Combining High-Z Sensitized Radiotherapy with CD73 Blockade to Boost Tumor Immunotherapy
Qian Chen, Jing Chen, Qingqing Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 13, pp. 12087-12100
Closed Access | Times Cited: 16
Qian Chen, Jing Chen, Qingqing Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 13, pp. 12087-12100
Closed Access | Times Cited: 16
Nanoparticle-mediated immunogenic cell death for cancer immunotherapy
Haolong Qi, Yuan Li, Yingjie Geng, et al.
International Journal of Pharmaceutics (2024) Vol. 656, pp. 124045-124045
Closed Access | Times Cited: 5
Haolong Qi, Yuan Li, Yingjie Geng, et al.
International Journal of Pharmaceutics (2024) Vol. 656, pp. 124045-124045
Closed Access | Times Cited: 5
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
A Peptide Nanoregulator Enriched at the Endoplasmic Reticulum for Boosting Fractionated Radiotherapy‐Mediated Antitumor Immune Response
Xiaoyao Cai, Dianyu Wang, Wei Xu, et al.
Advanced Functional Materials (2025)
Closed Access
Xiaoyao Cai, Dianyu Wang, Wei Xu, et al.
Advanced Functional Materials (2025)
Closed Access
Calreticulin—From the Endoplasmic Reticulum to the Plasma Membrane—Adventures of a Wandering Protein
Gillian C. Okura, Alamelu G. Bharadwaj, David M. Waisman
Cancers (2025) Vol. 17, Iss. 2, pp. 288-288
Open Access
Gillian C. Okura, Alamelu G. Bharadwaj, David M. Waisman
Cancers (2025) Vol. 17, Iss. 2, pp. 288-288
Open Access
An NIR‐II Absorbing Injectable Hydrogel for Boosted Photo‐Immunotherapy Toward Human Papillomavirus Associated Cancer
Xinghua Yu, Lingan Zeng, Xinyue Yang, et al.
Aggregate (2025)
Open Access
Xinghua Yu, Lingan Zeng, Xinyue Yang, et al.
Aggregate (2025)
Open Access
Impact of Timing the Combination of Radiotherapy and PD-1 Inhibitors on Outcomes in Patients with Hepatocellular Carcinoma
Liting Zhong, Weiwei Peng, Jingyuan Sun, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 123-134
Open Access
Liting Zhong, Weiwei Peng, Jingyuan Sun, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 123-134
Open Access
A pH-responsive PROTAC-based nanosystem triggers tumor-specific ferroptosis to construct in situ tumor vaccines
Linghong Huang, Xin‐Yuan Sun, Qinhua Zuo, et al.
Materials Today Bio (2025) Vol. 31, pp. 101523-101523
Open Access
Linghong Huang, Xin‐Yuan Sun, Qinhua Zuo, et al.
Materials Today Bio (2025) Vol. 31, pp. 101523-101523
Open Access
